Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_40477 | 87 | 1.80 | Mlig455_066098, Mlig455_068673 | Neo: - Age: - Regeneration-downregulated R4: -4.243 Regeneration-depleted R4: -4.243 |
SSUH2 | Mlig455_066098 {REF} {Length: 1581} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=108, Expect=1e-26]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=104, Expect=3e-25]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=69.3, Expect=4e-13]} {RNA1310_23200} {RNA815_29266} Mlig455_068673 {REF} {Length: 1558} {Pfam: DnaJ central domain [PF00684.21, score=24.8]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=216, Expect=8e-66]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=165, Expect=6e-47]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [RH, Score=140, Expect=2e-37]} {RNA1310_23200} {RNA815_29266} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.7 | 1.837 | 1.00000 | 1.00000 | |
RegionR2 | 0.733 | 1.837 | 0.52591 | 0.89879 | |
RegionR3 | -0.791 | 1.837 | 0.90976 | 1.00000 | |
RegionR4 | 2.798 | 1.837 | 0.03528 | 0.15224 | |
RegionR5 | 0.524 | 1.837 | 0.57830 | 0.93696 | |
RegionR6 | 0.821 | 1.837 | 0.45784 | 1.00000 | |
RegionR7 | 2.224 | 1.837 | 0.08288 | 0.55443 | |
RegionR8 | -4.61 | 1.837 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.74 | 1.837 | 0.99988 | 1.00000 | |
RegenerationR2 | -0.237 | 1.837 | 0.74134 | 0.97036 | |
RegenerationR3 | -0.3 | 1.837 | 0.79309 | 0.98001 | |
RegenerationR4 | -4.243 | 1.837 | 0.00014 | 0.00870 | Specific for R4: -4.243 |
RegenerationR5 | -0.982 | 1.837 | 0.27903 | 0.70858 | |
RegenerationR6 | -0.401 | 1.837 | 0.65766 | 0.90210 | |
RegenerationBL | -3.745 | 1.837 | 0.99996 | 1.00000 | |
RegenerationTP | 2.598 | 1.837 | 0.19135 | 0.63009 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_40477 | 87 | 1.8 | Mlig455_066098, Mlig455_068673 | Neo: - Age: - Regeneration-downregulated R4: -4.243 Regeneration-depleted R4: -4.243 |
SSUH2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_066098 {REF} {Length: 1581} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=108, Expect=1e-26]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=104, Expect=3e-25]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=69.3, Expect=4e-13]} {RNA1310_23200} {RNA815_29266} Mlig455_068673 {REF} {Length: 1558} {Pfam: DnaJ central domain [PF00684.21, score=24.8]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [RH, Score=216, Expect=8e-66]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=165, Expect=6e-47]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [RH, Score=140, Expect=2e-37]} {RNA1310_23200} {RNA815_29266} |
2. | MligTC455_42454 | 1804 | 37.58 | Mlig455_044488 | Neo: - Age: - Region-enriched R7: 3.309/0.00000 Regeneration-downregulated BL: -5.601 Regeneration-depleted BL: -5.601 |
2.569 | 0.746 | - | - | 0.861 | - | 0.962 | Mlig455_044488 {REF} {Length: 3520} {Pfam: Domain of unknown function (DUF4735) [PF15882.7, score=197.2]} {Smed: dd_Smed_v6_21285_0_1, dd_Smed_v6_21285_0_1, [RH, Score=209, Expect=9e-65]} {RNA1509_24134} {RNA1310_20974} {RNA815_11272} | |
3. | MligTC455_48909 | 93 | 1.94 | Mlig455_048405, Mlig455_049069 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.490 Region-enriched R2: 4.721/0.03142 |
ASIC1 | 1.879 | - | - | - | 0.987 | - | 0.892 | Mlig455_048405 {REF} {Length: 2732} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=163.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=51.6, Expect=4e-06]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=55.8, Expect=1e-07]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=55.1, Expect=2e-07]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=112, Expect=8e-26]} {RNA1310_26678} {RNA815_24347} Mlig455_049069 {REF} {Length: 2732} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=163.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=51.2, Expect=5e-06]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=55.8, Expect=1e-07]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=55.1, Expect=2e-07]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=112, Expect=8e-26]} {RNA1310_26678} {RNA815_24347} |
4. | MligTC455_45683 | 346 | 7.21 | Mlig455_067172 | Neo: - Age: Down-Up-Down Region-enriched R7: 4.371/0.00009 |
1.844 | - | - | - | 0.977 | - | 0.867 | Mlig455_067172 {REF} {Length: 932} {Pfam: Late nodulin protein [PF07127.13, score=20.1]} {RNA1310_45419} {RNA815_22274} | |
5. | MligTC455_20332 | 34 | 0.71 | Mlig455_038515 | Neo: - Age: - |
1.819 | 0.851 | - | - | 0.968 | - | - | Mlig455_038515 {REF} {Length: 2092} {RNA1509_52468} {RNA1310_41235} {RNA815_11414.1} | |
6. | MligTC455_37269 | 173 | 3.61 | Mlig455_020047 | Neo: - Age: - |
CASP3 | 1.81 | - | - | - | 0.837 | - | 0.973 | Mlig455_020047 {REF} {Length: 2828} {Pfam: Caspase domain [PF00656.24, score=94.7]; Ankyrin repeats (3 copies) [PF12796.9, score=79.1]; Ankyrin repeats (many copies) [PF13857.8, score=62.0]; Ankyrin repeats (many copies) [PF13637.8, score=58.0]; Ankyrin repeat [PF13606.8, score=40.7]; Ankyrin repeat [PF00023.32, score=31.7]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=111, Expect=1e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]} {Mouse: ENSMUSG00000031628, Casp3, caspase 3, [Score=106, Expect=5e-25]; ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=7e-25]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=2e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_10883_0_1, dd_Smed_v6_10883_0_1, [Score=107, Expect=1e-24]} {RNA1509_54818} {RNA1310_7187} {RNA815_8712} |
7. | MligTC455_42887 | 60 | 1.24 | Mlig455_036468, Mlig455_056252 | Neo: - Age: - |
CCKAR | 1.803 | - | - | - | 0.848 | - | 0.955 | Mlig455_036468 {REF} {Length: 2390} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=81.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=37.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.5]} {Human: ENSG00000163394, CCKAR, cholecystokinin A receptor, [Score=53.5, Expect=5e-07]; ENSG00000170425, ADORA2B, adenosine A2b receptor, [Score=53.1, Expect=4e-07]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=59.3, Expect=4e-09]} {Dmel: FBgn0264002, MsR2, Myosuppressin receptor 2, [Score=57.0, Expect=3e-08]} {Celegans: WBGene00016428, dmsr-7, DroMyoSuppressin Receptor related, [Score=68.6, Expect=3e-12]} {Smed: dd_Smed_v6_9550_0_1, dd_Smed_v6_9550_0_1, [Score=69.7, Expect=9e-13]} {RNA1310_37299} {RNA815_29990} Mlig455_056252 {REF} {Length: 2265} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.8]} {RNA1310_56612} {RNA815_44133} |
8. | MligTC455_47741 | 102 | 2.13 | Mlig455_004211 | Neo: - Age: Down-Up-Up |
1.776 | - | - | - | 0.952 | - | 0.824 | Mlig455_004211 {REF} {Length: 1794} {RNA1310_23101} {RNA815_45601} | |
9. | MligTC455_51517 | 58 | 1.2 | Mlig455_009258 | Neo: - Age: - Region-enriched R7: 4.573/0.00239 |
1.768 | 0.815 | - | - | - | - | 0.953 | Mlig455_009258 {REF} {Length: 7134} {RNA1509_45796} {RNA1310_11885} {RNA815_30863} | |
10. | MligTC455_53382 | 110 | 2.28 | Mlig455_006777 | Neo: - Age: - |
1.762 | - | - | - | 0.952 | - | 0.810 | Mlig455_006777 {REF} {Length: 2841} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.8]} {Dmel: FBgn0039747, AdoR, Adenosine receptor, [Score=48.9, Expect=1e-05]} {Smed: dd_Smed_v6_8885_0_1, dd_Smed_v6_8885_0_1, [Score=137, Expect=6e-36]} {RNA1509_47534} {RNA1310_15311} {RNA815_12841} | |
11. | MligTC455_39518 | 40 | 0.83 | Mlig455_031401 | Neo: - Age: - |
CHRNA1 | 1.747 | - | - | - | 0.967 | - | 0.780 | Mlig455_031401 {REF} {Length: 2411} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=92.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=76.4]} {Human: ENSG00000138435, CHRNA1, cholinergic receptor nicotinic alpha 1 subunit, [Score=120, Expect=3e-29]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=120, Expect=2e-29]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=115, Expect=2e-27]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=114, Expect=3e-27]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=134, Expect=2e-34]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=135, Expect=1e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=124, Expect=5e-31]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=114, Expect=2e-27]} {RNA1509_53098} {RNA1310_67430} {RNA815_23438} |
12. | MligTC455_40260 | 7083 | 147.57 | Mlig455_058193 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.425 Region-enriched R7: 5.743/0.00000 Regeneration-depleted BL: -13.476 |
AVP | 1.727 | 0.761 | - | - | - | - | 0.966 | Mlig455_058193 {REF} {Length: 1929} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=58.6]} {Human: ENSG00000101200, AVP, arginine vasopressin, [RH, Score=58.5, Expect=2e-10]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [RH, Score=63.9, Expect=2e-12]} {RNA1509_15970} {RNA1310_46866} {RNA815_23759} |
13. | MligTC455_53639 | 20 | 0.42 | Mlig455_033414 | Neo: - Age: - |
1.71 | - | - | - | 0.980 | - | 0.730 | Mlig455_033414 {REF} {Length: 198} {NoTransDecoderORF} {RNA1310_131793} | |
14. | MligTC455_43389 | 18 | 0.38 | Mlig455_019091 | Neo: - Age: - |
PRKAR2A | 1.701 | - | - | 0.722 | 0.979 | - | - | Mlig455_019091 {REF} {Length: 2410} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.4]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=297, Expect=5e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=297, Expect=5e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=313, Expect=9e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=6e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
15. | MligTC455_16471 | 45 | 0.94 | Mlig455_042944 | Neo: - Age: - |
NKX2-3 | 1.692 | - | - | - | 0.954 | 0.738 | - | Mlig455_042944 {REF} {Length: 1426} {Pfam: Homeodomain [PF00046.31, score=67.5]} {Human: ENSG00000119919, NKX2-3, NK2 homeobox 3, [RH, Score=122, Expect=1e-31]} {Mouse: ENSMUSG00000044220, Nkx2-3, NK2 homeobox 3, [RH, Score=122, Expect=2e-31]} {Dmel: FBgn0028993, scro, scarecrow, [Score=106, Expect=3e-26]} {Celegans: WBGene00000450, ceh-28, C. Elegans Homeobox; NK-2 family homeodomain protein CEH-28, [RH, Score=97.8, Expect=4e-24]} {Smed: dd_Smed_v6_6729_0_1, dd_Smed_v6_6729_0_1, [Score=109, Expect=3e-27]} {RNA1310_91075} |
16. | MligTC455_15755 | 62 | 1.3 | Mlig455_051284 | Neo: - Age: - Region-enriched R7: 4.959/0.00065 |
CHRNB3 | 1.655 | 0.701 | - | - | - | - | 0.954 | Mlig455_051284 {REF} {Length: 2666} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=130.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=32.4]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=142, Expect=1e-37]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=139, Expect=2e-36]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=137, Expect=1e-35]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=160, Expect=5e-44]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=146, Expect=9e-39]} {Celegans: WBGene00020048, lgc-12, Ligand-Gated ion Channel, [Score=140, Expect=2e-37]} {Smed: dd_Smed_v6_29533_0_1, dd_Smed_v6_29533_0_1, [RH, Score=205, Expect=1e-61]} {RNA1310_22037} {RNA815_37244} |
17. | MligTC455_33239 | 57 | 1.18 | Mlig455_006962 | Neo: - Age: - |
CACNG5 | 0.994 | - | - | - | 0.994 | - | - | Mlig455_006962 {REF} {Length: 1957} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=72.5]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=60.2]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=91.3, Expect=5e-20]; ENSG00000105605, CACNG7, calcium voltage-gated channel auxiliary subunit gamma 7, [Score=89.0, Expect=4e-19]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=90.1, Expect=9e-20]; ENSMUSG00000069806, Cacng7, calcium channel, voltage-dependent, gamma subunit 7, [Score=89.0, Expect=3e-19]; ENSMUSG00000096998, Cacng7, calcium channel, voltage-dependent, gamma subunit 7, [Score=89.0, Expect=3e-19]} {Dmel: FBgn0064123, stg1, stargazin-like protein, [Score=62.0, Expect=6e-10]} {Smed: dd_Smed_v6_20066_0_1, dd_Smed_v6_20066_0_1, [RH, Score=228, Expect=2e-68]} {RNA1310_39723} {RNA815_37605} |
18. | MligTC455_40756 | 35 | 0.73 | Mlig455_050356, Mlig455_065112 | Neo: - Age: - |
0.993 | - | - | - | 0.993 | - | - | Mlig455_050356 {REF} {Length: 740} {NoTransDecoderORF} {RNA1509_38191} {RNA1310_5321.1} {RNA815_14836} Mlig455_065112 {REF} {Length: 277} {NoTransDecoderORF} {RNA1509_38191} {RNA1310_5321.1} {RNA815_14836} |
|
19. | MligTC455_08913 | 11 | 0.23 | Mlig455_010158, Mlig455_010225 | Neo: - Age: - |
KCNN1 | 0.991 | - | - | - | 0.991 | - | - | Mlig455_010158 {REF} {Length: 2236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=124.1]; Calmodulin binding domain [PF02888.18, score=76.7]; Ion channel [PF07885.18, score=53.1]} {Human: ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=384, Expect=2e-128]; ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=378, Expect=1e-125]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=374, Expect=3e-122]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=378, Expect=8e-126]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=372, Expect=1e-121]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=390, Expect=3e-131]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=318, Expect=3e-102]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [Score=451, Expect=4e-156]} {RNA1310_35938} {RNA815_50883} Mlig455_010225 {REF} {Length: 2486} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=124.1]; Calmodulin binding domain [PF02888.18, score=76.7]; Ion channel [PF07885.18, score=53.1]} {Human: ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [Score=384, Expect=2e-128]; ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [Score=378, Expect=1e-125]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [Score=374, Expect=3e-122]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [Score=378, Expect=8e-126]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [Score=372, Expect=1e-121]; ENSMUSG00000111706, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]; ENSMUSG00000002908, Kcnn1, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1, [Score=369, Expect=1e-122]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [Score=390, Expect=3e-131]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [Score=318, Expect=3e-102]} {Smed: dd_Smed_v6_13309_0_1, dd_Smed_v6_13309_0_1, [Score=451, Expect=4e-156]} {RNA1310_35938} {RNA815_50883} |
20. | MligTC455_40649 | 24 | 0.49 | Mlig455_066232 | Neo: - Age: - |
0.987 | - | - | - | 0.987 | - | - | Mlig455_066232 {REF} {Length: 2453} {RNA1310_42980.1} {RNA815_47590} | |
21. | MligTC455_37342 | 203 | 4.23 | Mlig455_024018 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_024018 {REF} {Length: 1374} {RNA1509_59718} {RNA1310_33285} {RNA815_22262} | |
22. | MligTC455_09196 | 28 | 0.59 | Mlig455_046836 | Neo: - Age: - |
0.975 | - | - | - | - | - | 0.975 | Mlig455_046836 {REF} {Length: 3502} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=187.1]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=62.4, Expect=9e-10]} {Smed: dd_Smed_v6_8949_0_1, dd_Smed_v6_8949_0_1, [Score=75.1, Expect=6e-14]} {RNA1509_28410} {RNA1310_44135} {RNA815_33213} | |
23. | MligTC455_49670 | 33 | 0.68 | Mlig455_047674 | Neo: Int S/G2/M Age: - Region-enriched R2: 4.520/0.04813 |
WSCD2 | 0.974 | - | - | 0.974 | - | - | - | Mlig455_047674 {REF} {Length: 875} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=53.1, Expect=9e-08]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=52.8, Expect=9e-08]} {RNA1509_29094} {RNA1310_84271.1} {RNA815_51632} |
24. | MligTC455_10060 | 252 | 5.25 | Mlig455_045586, Mlig455_045588, Mlig455_045645 | Neo: - Age: - Region-enriched R3: 5.577/0.00014 |
0.973 | - | - | - | 0.973 | - | - | Mlig455_045586 {REF} {Length: 436} {NoTransDecoderORF} {RNA1310_84637} {RNA815_42836.2} Mlig455_045588 {REF} {Length: 472} {RNA1310_84637} {RNA815_42836.2} Mlig455_045645 {REF} {Length: 489} {RNA1310_84637} {RNA815_42836.2} |
|
25. | MligTC455_36963 | 39 | 0.81 | Mlig455_050201 | Neo: - Age: Up-Down-Down |
AVPR1B | 0.971 | - | - | - | - | - | 0.971 | Mlig455_050201 {REF} {Length: 2792} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=152.5]; Olfactory receptor [PF13853.8, score=29.2]} {Human: ENSG00000198049, AVPR1B, arginine vasopressin receptor 1B, [Score=92.8, Expect=1e-19]} {Mouse: ENSMUSG00000049112, Oxtr, oxytocin receptor, [Score=94.0, Expect=3e-20]} {Dmel: FBgn0025595, AkhR, Adipokinetic hormone receptor, [Score=80.5, Expect=7e-16]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=79.0, Expect=3e-15]} {Smed: dd_Smed_v6_45004_0_1, dd_Smed_v6_45004_0_1, [Score=69.7, Expect=8e-13]} {RNA1310_72444} {RNA815_35126} |
26. | MligTC455_45968 | 43 | 0.89 | Mlig455_058916 | Neo: - Age: - |
0.971 | - | - | - | - | - | 0.971 | Mlig455_058916 {REF} {Length: 3026} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=53.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=29.4]} {Smed: dd_Smed_v6_27761_0_1, dd_Smed_v6_27761_0_1, [RH, Score=105, Expect=7e-25]} {RNA1310_38706} | |
27. | MligTC455_51650 | 92 | 1.93 | Mlig455_036750 | Neo: - Age: - Region-enriched R2: 3.192/0.03650 |
ARL3 | 0.971 | - | - | - | - | - | 0.971 | Mlig455_036750 {REF} {Length: 2942} {Pfam: ADP-ribosylation factor family [PF00025.23, score=98.6]; G-protein alpha subunit [PF00503.22, score=36.0]; Signal recognition particle receptor beta subunit [PF09439.12, score=35.5]; 50S ribosome-binding GTPase [PF01926.25, score=20.6]; Ras family [PF00071.24, score=20.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=19.6]} {Human: ENSG00000138175, ARL3, ADP ribosylation factor like GTPase 3, [Score=81.3, Expect=2e-18]; ENSG00000188042, ARL4C, ADP ribosylation factor like GTPase 4C, [Score=81.3, Expect=3e-18]; ENSG00000134287, ARF3, ADP ribosylation factor 3, [Score=78.6, Expect=2e-17]; ENSG00000143761, ARF1, ADP ribosylation factor 1, [Score=78.2, Expect=2e-17]} {Mouse: ENSMUSG00000034936, Arl4d, ADP-ribosylation factor-like 4D, [Score=84.7, Expect=8e-20]; ENSMUSG00000025035, Arl3, ADP-ribosylation factor-like 3, [Score=82.4, Expect=5e-19]; ENSMUSG00000049866, Arl4c, ADP-ribosylation factor-like 4C, [Score=80.9, Expect=2e-18]} {Dmel: FBgn0038916, dnd, dead end, [Score=82.8, Expect=2e-19]} {Celegans: WBGene00000188, arl-3, ADP-ribosylation factor-like protein 3, [Score=86.3, Expect=1e-20]} {Smed: dd_Smed_v6_2013_0_1, dd_Smed_v6_2013_0_1, [Score=102, Expect=3e-27]} {RNA1310_52038} {RNA815_22575.1} |
28. | MligTC455_07256 | 15 | 0.31 | Mlig455_030099 | Neo: - Age: - |
0.97 | - | - | - | - | - | 0.970 | Mlig455_030099 {REF} {Length: 739} {NoTransDecoderORF} {RNA1509_58900} {RNA1310_3821} {RNA815_7300} | |
29. | MligTC455_26366 | 75 | 1.56 | Mlig455_013893 | Neo: - Age: - |
NSUN7 | 0.97 | - | - | - | - | - | 0.970 | Mlig455_013893 {REF} {Length: 1904} {Human: ENSG00000179299, NSUN7, NOP2/Sun RNA methyltransferase family member 7, [Score=167, Expect=4e-45]} {Mouse: ENSMUSG00000029206, Nsun7, NOL1/NOP2/Sun domain family, member 7, [Score=164, Expect=3e-44]} {Dmel: FBgn0266099, CG44836, [Score=72.8, Expect=2e-13]} {Celegans: WBGene00013151, nsun-5, Nop2 (NOP2)/SUN domain family member, [Score=56.2, Expect=2e-08]} {Smed: dd_Smed_v6_30093_0_1, dd_Smed_v6_30093_0_1, [Score=203, Expect=3e-60]} {RNA1310_17601} {RNA815_32144} |
30. | MligTC455_42287 | 73 | 1.52 | Mlig455_042810 | Neo: - Age: - |
NPFFR1 | 0.97 | - | - | - | 0.970 | - | - | Mlig455_042810 {REF} {Length: 1659} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=87.4]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=64.7, Expect=8e-11]} {Mouse: ENSMUSG00000020090, Npffr1, neuropeptide FF receptor 1, [Score=68.9, Expect=2e-12]; ENSMUSG00000048337, Npy4r, neuropeptide Y receptor Y4, [Score=65.5, Expect=2e-11]} {Dmel: FBgn0004622, TkR99D, Tachykinin-like receptor at 99D, [Score=83.6, Expect=3e-17]} {Celegans: WBGene00021897, ser-6, SERotonin/octopamine receptor family, [Score=65.1, Expect=2e-11]} {Smed: dd_Smed_v6_45004_0_1, dd_Smed_v6_45004_0_1, [Score=69.7, Expect=5e-13]} {RNA1310_19087.2} {RNA815_19700} |
31. | MligTC455_17376 | 103 | 2.15 | Mlig455_020346 | Neo: - Age: - |
0.968 | - | - | - | - | - | 0.968 | Mlig455_020346 {REF} {Length: 1093} {NoTransDecoderORF} {RNA1310_106511} | |
32. | MligTC455_10816 | 14 | 0.29 | Mlig455_027523, Mlig455_046082, Mlig455_061029 | Neo: - Age: - |
0.966 | - | - | - | - | - | 0.966 | Mlig455_027523 {REF} {Length: 383} {RNA1310_79750} Mlig455_046082 {REF} {Length: 352} Mlig455_061029 {REF} {Length: 475} {RNA1310_79750} |
|
33. | MligTC455_12661 | 25 | 0.51 | Mlig455_063823 | Neo: - Age: - |
0.965 | - | - | - | 0.965 | - | - | Mlig455_063823 {REF} {Length: 1191} {RNA1310_131240} | |
34. | MligTC455_02412 | 75 | 1.56 | Mlig455_011577 | Neo: - Age: - Region-enriched R6: 6.973/0.00029 |
0.964 | - | - | - | - | - | 0.964 | Mlig455_011577 {REF} {Length: 2541} {RNA1310_57680} {RNA815_62505} | |
35. | MligTC455_35561 | 23 | 0.47 | Mlig455_058398 | Neo: - Age: - |
0.964 | - | - | - | 0.964 | - | - | Mlig455_058398 {REF} {Length: 576} {NoTransDecoderORF} | |
36. | MligTC455_26004 | 161 | 3.34 | Mlig455_005523, Mlig455_036228 | Neo: - Age: logFC(26M/2M)=0.483 Region-enriched R2: 3.880/0.02863 |
0.963 | - | - | - | 0.963 | - | - | Mlig455_005523 {REF} {Length: 3106} {RNA1509_54312} {RNA1310_125315} {RNA815_31978} Mlig455_036228 {REF} {Length: 3817} {RNA1509_54312} {RNA1310_75243} {RNA815_31978} |
|
37. | MligTC455_00897 | 25 | 0.53 | Mlig455_066029 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_066029 {REF} {Length: 4211} {RNA1310_41937} {RNA815_46698} | |
38. | MligTC455_41783 | 9 | 0.19 | Mlig455_040164 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_040164 {REF} {Length: 1537} {NoTransDecoderORF} {RNA1509_25839} {RNA1310_89098} {RNA815_55582} | |
39. | MligTC455_06426 | 14 | 0.3 | Mlig455_045703 | Neo: - Age: - |
0.961 | - | - | 0.961 | - | - | - | Mlig455_045703 {REF} {Length: 756} {NoTransDecoderORF} {RNA1310_88574} {RNA815_52979} | |
40. | MligTC455_24861 | 117 | 2.44 | Mlig455_019572 | Neo: - Age: - Region-enriched R8: 4.245/0.00630 |
FREM1 | 0.961 | - | - | - | - | - | 0.961 | Mlig455_019572 {REF} {Length: 8695} {Pfam: Cadherin-like [PF16184.7, score=328.8]; Frem protein N-terminal domain [PF19309.1, score=92.3]; Lectin C-type domain [PF00059.23, score=31.6]} {Human: ENSG00000164946, FREM1, FRAS1 related extracellular matrix 1, [RH, Score=370, Expect=2e-102]} {Mouse: ENSMUSG00000059049, Frem1, Fras1 related extracellular matrix protein 1, [RH, Score=381, Expect=3e-106]} {Smed: dd_Smed_v6_5187_0_1, dd_Smed_v6_5187_0_1, [RH, Score=508, Expect=4e-147]} {RNA1509_8234} {RNA1310_595.1} {RNA815_322} |
41. | MligTC455_56513 | 8 | 0.16 | Mlig455_010760 | Neo: - Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_010760 {REF} {Length: 154} {NoTransDecoderORF} | |
42. | MligTC455_25135 | 288 | 6 | Mlig455_001749, Mlig455_001771 | Neo: - Age: - Region-enriched R2: 2.329/0.04280 |
P2RX4 | 0.96 | - | - | - | 0.960 | - | - | Mlig455_001749 {REF} {Length: 2951} {Pfam: ATP P2X receptor [PF00864.21, score=341.3]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=247, Expect=3e-75]; ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=235, Expect=5e-70]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=248, Expect=1e-75]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=236, Expect=3e-70]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=316, Expect=7e-101]} {RNA1509_56054} {RNA1310_19416, RNA1509_56054} {RNA1509_56054, RNA815_42167} Mlig455_001771 {REF} {Length: 2484} {Pfam: ATP P2X receptor [PF00864.21, score=341.3]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=247, Expect=3e-75]; ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=235, Expect=5e-70]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=248, Expect=1e-75]; ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=236, Expect=3e-70]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=316, Expect=7e-101]} {RNA1509_56054} {RNA1310_19416} {RNA815_42167} |
43. | MligTC455_24548 | 39 | 0.8 | Mlig455_031981 | Neo: - Age: - |
ROBO1 | 0.959 | - | - | - | - | - | 0.959 | Mlig455_031981 {REF} {Length: 4163} {Pfam: Immunoglobulin domain [PF13927.8, score=128.2]; Immunoglobulin I-set domain [PF07679.18, score=115.2]; Immunoglobulin domain [PF00047.27, score=78.6]; Immunoglobulin V-set domain [PF07686.19, score=73.6]; Immunoglobulin domain [PF13895.8, score=71.9]; Fibronectin type III domain [PF00041.23, score=22.4]} {Human: ENSG00000169855, ROBO1, roundabout guidance receptor 1, [Score=164, Expect=3e-40]} {Mouse: ENSMUSG00000032128, Robo3, roundabout guidance receptor 3, [Score=133, Expect=6e-31]} {Dmel: FBgn0005631, robo1, roundabout 1, [Score=139, Expect=4e-33]} {Celegans: WBGene00004729, sax-3, [Score=132, Expect=6e-31]} {Smed: dd_Smed_v6_8494_0_1, dd_Smed_v6_8494_0_1, [Score=239, Expect=1e-64]} {RNA1310_122847} {RNA815_62158} |
44. | MligTC455_45682 | 167 | 3.49 | Mlig455_065509 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_065509 {REF} {Length: 811} {Pfam: Late nodulin protein [PF07127.13, score=20.4]} {RNA1310_45419} {RNA815_22274} | |
45. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
0.959 | - | - | - | 0.959 | - | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
46. | MligTC455_25989 | 157 | 3.27 | Mlig455_048336 | Neo: - Age: - |
TMEM184B | 0.956 | - | - | - | - | - | 0.956 | Mlig455_048336 {REF} {Length: 2156} {TRANSSPLICED} {Pfam: Organic solute transporter Ostalpha [PF03619.18, score=289.7]} {Human: ENSG00000198792, TMEM184B, transmembrane protein 184B, [RH, Score=454, Expect=3e-158]} {Mouse: ENSMUSG00000009035, Tmem184b, transmembrane protein 184b, [RH, Score=449, Expect=1e-156]} {Dmel: FBgn0035236, CG12004, [RH, Score=462, Expect=1e-160]} {Celegans: WBGene00009574, F40E10.6, [RH, Score=469, Expect=8e-165]} {Smed: dd_Smed_v6_3881_1_1, dd_Smed_v6_3881_1_1, [RH, Score=457, Expect=1e-160]} {RNA1509_20649} {RNA1310_20202, RNA1509_20649} {RNA1509_20649, RNA815_8572} |
47. | MligTC455_43307 | 242 | 5.04 | Mlig455_061239 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_061239 {REF} {Length: 792} {NoTransDecoderORF} {RNA1509_38062} {RNA1310_36873} {RNA815_8442.1} | |
48. | MligTC455_14328 | 585 | 12.19 | Mlig455_035956, Mlig455_058425 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=3.032 Region-enriched R2: 6.210/0.01234 |
CYP2U1 | 0.955 | - | - | - | - | - | 0.955 | Mlig455_035956 {REF} {Length: 4315} {Pfam: Cytochrome P450 [PF00067.24, score=301.9]} {Human: ENSG00000155016, CYP2U1, cytochrome P450 family 2 subfamily U member 1, [Score=213, Expect=5e-62]; ENSG00000108242, CYP2C18, cytochrome P450 family 2 subfamily C member 18, [Score=205, Expect=9e-60]} {Mouse: ENSMUSG00000032808, Cyp2c38, cytochrome P450, family 2, subfamily c, polypeptide 38, [Score=215, Expect=9e-64]; ENSMUSG00000025003, Cyp2c39, cytochrome P450, family 2, subfamily c, polypeptide 39, [Score=214, Expect=3e-63]; ENSMUSG00000116063, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000027983, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [Score=212, Expect=2e-62]; ENSMUSG00000052974, Cyp2f2, cytochrome P450, family 2, subfamily f, polypeptide 2, [Score=208, Expect=5e-61]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=179, Expect=5e-50]} {Celegans: WBGene00016697, cyp-33C2, CYtochrome P450 family, [Score=206, Expect=3e-60]} {Smed: dd_Smed_v6_2083_0_1, dd_Smed_v6_2083_0_1, [Score=226, Expect=7e-68]} {RNA1509_49553} {RNA1310_2911.1} {RNA815_12179} Mlig455_058425 {REF} {Length: 2850} {Pfam: Cytochrome P450 [PF00067.24, score=301.9]} {Human: ENSG00000155016, CYP2U1, cytochrome P450 family 2 subfamily U member 1, [Score=213, Expect=5e-62]; ENSG00000108242, CYP2C18, cytochrome P450 family 2 subfamily C member 18, [Score=205, Expect=9e-60]} {Mouse: ENSMUSG00000032808, Cyp2c38, cytochrome P450, family 2, subfamily c, polypeptide 38, [Score=215, Expect=9e-64]; ENSMUSG00000025003, Cyp2c39, cytochrome P450, family 2, subfamily c, polypeptide 39, [Score=214, Expect=3e-63]; ENSMUSG00000116063, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000027983, Cyp2u1, cytochrome P450, family 2, subfamily u, polypeptide 1, [Score=213, Expect=2e-62]; ENSMUSG00000052914, Cyp2j6, cytochrome P450, family 2, subfamily j, polypeptide 6, [Score=212, Expect=2e-62]; ENSMUSG00000052974, Cyp2f2, cytochrome P450, family 2, subfamily f, polypeptide 2, [Score=208, Expect=5e-61]} {Dmel: FBgn0010383, Cyp18a1, Cytochrome P450-18a1, [Score=179, Expect=5e-50]} {Celegans: WBGene00016697, cyp-33C2, CYtochrome P450 family, [Score=206, Expect=3e-60]} {Smed: dd_Smed_v6_2083_0_1, dd_Smed_v6_2083_0_1, [Score=226, Expect=7e-68]} {RNA1509_49553} {RNA1310_2911.1, RNA1509_49553} {RNA1509_49553, RNA815_12179} |
49. | MligTC455_43504 | 2388 | 49.76 | Mlig455_055223 | Neo: - Age: - |
0.955 | - | - | - | 0.955 | - | - | Mlig455_055223 {REF} {Length: 911} {RNA1509_17222} {RNA1310_44913.1} {RNA815_37256} | |
50. | MligTC455_10178 | 77 | 1.6 | Mlig455_017978 | Neo: - Age: - Region-enriched R7: 6.377/0.00000 |
GRM3 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_017978 {REF} {Length: 3464} {Pfam: Receptor family ligand binding region [PF01094.30, score=224.4]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=185.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=39.1]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=670, Expect=0.0]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=725, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=625, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=803, Expect=0.0]} {RNA1310_41220} |
51. | MligTC455_43507 | 1112 | 23.16 | Mlig455_055318 | Neo: - Age: logFC(26M/2M)=0.860 Region-enriched R3: 2.019/0.02166 |
0.954 | - | - | - | 0.954 | - | - | Mlig455_055318 {REF} {Length: 948} {RNA1509_17222} {RNA1310_44913.2} {RNA815_37256} | |
52. | MligTC455_55791 | 13 | 0.26 | Mlig455_064674 | Neo: - Age: - |
0.954 | - | - | - | - | - | 0.954 | Mlig455_064674 {REF} {Length: 343} {NoTransDecoderORF} | |
53. | MligTC455_42270 | 1491 | 31.07 | Mlig455_038876, Mlig455_055368, Mlig455_063840 | Neo: - Age: - Region-enriched R2: 3.738/0.00095 |
0.953 | - | - | - | 0.953 | - | - | Mlig455_038876 {REF} {Length: 356} {RNA1509_31676} {RNA1310_69347} {RNA815_36089} Mlig455_055368 {REF} {Length: 574} {RNA1509_31676, RNA1509_43695} {RNA1310_69347, RNA1509_31676, RNA1509_43695} {RNA1509_31676, RNA1509_43695, RNA815_36089} Mlig455_063840 {REF} {Length: 568} {RNA1509_31676} {RNA1310_69347} {RNA815_36089} |
|
54. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 0.953 | - | - | - | 0.953 | - | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
55. | MligTC455_05944 | 15 | 0.31 | Mlig455_029040 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_029040 {REF} {Length: 514} {NoTransDecoderORF} {RNA1509_29524} {RNA1310_69080} {RNA815_44442} | |
56. | MligTC455_31726 | 371 | 7.74 | Mlig455_018621 | Neo: - |
QKI | 0.952 | - | - | - | - | 0.952 | - | Mlig455_018621 {REF} {Length: 3981} {TRANSSPLICED} {Pfam: Homodimerisation region of STAR domain protein [PF16544.7, score=72.3]} {Human: ENSG00000112531, QKI, QKI, KH domain containing RNA binding, [RH, Score=257, Expect=9e-82]} {Mouse: ENSMUSG00000062078, Qk, quaking, [RH, Score=257, Expect=6e-82]} {Dmel: FBgn0264491, how, held out wings, [Score=241, Expect=2e-75]} {Celegans: WBGene00006423, asd-2, RNA-binding protein asd-2, [Score=231, Expect=5e-72]} {Smed: dd_Smed_v6_13063_0_1, dd_Smed_v6_13063_0_1, [Score=248, Expect=4e-78]} {RNA1509_45751, RNA1509_57462} {RNA1310_16506.1, RNA1509_45751} {RNA1509_45751, RNA815_14597} |
57. | MligTC455_41389 | 111 | 2.31 | Mlig455_024385 | Neo: - Age: - |
0.952 | - | - | - | - | - | 0.952 | Mlig455_024385 {REF} {Length: 569} {NoTransDecoderORF} {RNA1509_15591} {RNA1310_81202.1} {RNA815_31796} | |
58. | MligTC455_46201 | 1507 | 31.4 | Mlig455_003536 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=1.432 Region-enriched R7: 4.133/0.00000 Regeneration-downregulated BL: -4.010 Regeneration-depleted BL: -4.010 |
0.952 | - | - | - | - | - | 0.952 | Mlig455_003536 {REF} {Length: 1316} {RNA1509_40578} {RNA1310_31635.1} {RNA815_27083.1} | |
59. | MligTC455_14520 | 52 | 1.09 | Mlig455_064322, Mlig455_064353 | Neo: - Age: - |
0.951 | - | - | 0.951 | - | - | - | Mlig455_064322 {REF} {Length: 294} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_138105} Mlig455_064353 {REF} {Length: 960} {NoTransDecoderORF} {RNA1509_49770} {RNA1310_83801} {RNA815_12664} |
|
60. | MligTC455_44051 | 392 | 8.18 | Mlig455_008770, Mlig455_008804 | Neo: - Age: - Regeneration-downregulated BL: -5.343 Regeneration-depleted BL: -5.343 |
IPMK | 0.951 | - | - | - | - | - | 0.951 | Mlig455_008770 {REF} {Length: 3071} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=104.2]} {Human: ENSG00000151151, IPMK, inositol polyphosphate multikinase, [Score=112, Expect=8e-27]} {Mouse: ENSMUSG00000060733, Ipmk, inositol polyphosphate multikinase, [Score=106, Expect=4e-25]} {Dmel: FBgn0031267, Ipk2, [Score=111, Expect=1e-27]} {Celegans: WBGene00014081, impk-1, Kinase, [Score=71.2, Expect=1e-13]} {Smed: dd_Smed_v6_3701_0_1, dd_Smed_v6_3701_0_1, [Score=150, Expect=3e-42]} {RNA1509_8202} {RNA1310_21614.2} {RNA815_34405} Mlig455_008804 {REF} {Length: 2051} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=103.9]} {Human: ENSG00000151151, IPMK, inositol polyphosphate multikinase, [Score=112, Expect=4e-27]} {Mouse: ENSMUSG00000060733, Ipmk, inositol polyphosphate multikinase, [Score=107, Expect=1e-25]} {Dmel: FBgn0031267, Ipk2, [Score=113, Expect=2e-28]} {Celegans: WBGene00014081, impk-1, Kinase, [Score=71.2, Expect=9e-14]} {Smed: dd_Smed_v6_3701_0_1, dd_Smed_v6_3701_0_1, [Score=150, Expect=2e-42]} {RNA1509_8202} {RNA1310_21614.2} {RNA815_34405} |
61. | MligTC455_12451 | 63 | 1.31 | Mlig455_008444 | Neo: - Age: - Region-enriched R8: 4.645/0.00722 |
0.95 | - | - | - | - | - | 0.950 | Mlig455_008444 {REF} {Length: 791} | |
62. | MligTC455_21668 | 84 | 1.74 | Mlig455_024837 | Neo: - |
PPP3R1 | 0.95 | - | - | - | 0.950 | - | - | Mlig455_024837 {REF} {Length: 1650} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613} {RNA1310_16848.1} {RNA815_6272} |
63. | MligTC455_22736 | 174 | 3.62 | Mlig455_036576 | Neo: - Age: - Region-enriched R6: 5.263/0.00000 Regeneration-depleted R6: -8.651 |
PHEX | 0.95 | - | - | - | - | - | 0.950 | Mlig455_036576 {REF} {Length: 3336} {Pfam: Peptidase family M13 [PF01431.23, score=134.4]; Peptidase family M13 [PF05649.15, score=87.9]} {Human: ENSG00000102174, PHEX, phosphate regulating endopeptidase homolog X-linked, [Score=155, Expect=1e-38]; ENSG00000284917, EEF1AKMT4-ECE2, EEF1AKMT4-ECE2 readthrough, [Score=154, Expect=3e-38]; ENSG00000145194, ECE2, endothelin converting enzyme 2, [Score=154, Expect=2e-38]; ENSG00000196549, MME, membrane metalloendopeptidase, [Score=148, Expect=2e-36]} {Mouse: ENSMUSG00000022842, Ece2, endothelin converting enzyme 2, [Score=152, Expect=6e-38]; ENSMUSG00000115293, Gm49333, predicted gene, 49333, [Score=152, Expect=8e-38]; ENSMUSG00000027820, Mme, membrane metallo endopeptidase, [Score=148, Expect=1e-36]; ENSMUSG00000057457, Phex, phosphate regulating endopeptidase homolog, X-linked, [Score=146, Expect=6e-36]} {Dmel: FBgn0031081, Nep3, Neprilysin 3, [Score=135, Expect=2e-32]} {Celegans: WBGene00013926, nep-1, Neprilysin-1, [Score=155, Expect=4e-39]} {Smed: dd_Smed_v6_8276_0_1, dd_Smed_v6_8276_0_1, [Score=149, Expect=3e-37]} {RNA1509_47798} {RNA1310_6773, RNA1509_47798} {RNA1509_47798, RNA815_4414} |
64. | MligTC455_25896 | 2685 | 55.93 | Mlig455_028813 | Neo: - Age: - Regeneration-downregulated BL: -1.413 Regeneration-depleted BL: -1.413 |
SERINC3 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_028813 {REF} {Length: 2623} {TRANSSPLICED} {Pfam: Serine incorporator (Serinc) [PF03348.17, score=514.1]} {Human: ENSG00000132824, SERINC3, serine incorporator 3, [RH, Score=412, Expect=3e-140]} {Mouse: ENSMUSG00000019877, Serinc1, serine incorporator 1, [RH, Score=410, Expect=3e-140]} {Dmel: FBgn0028399, TMS1, [RH, Score=350, Expect=2e-116]} {Celegans: WBGene00021956, Y57E12AL.1, [RH, Score=374, Expect=8e-126]} {Smed: dd_Smed_v6_1130_0_1, dd_Smed_v6_1130_0_1, [RH, Score=515, Expect=0.0]} {RNA1509_48832, RNA1509_6329} {RNA1310_16171, RNA1509_48832, RNA1509_6329} {RNA1509_48832, RNA1509_6329, RNA815_6171} |
65. | MligTC455_48302 | 45 | 0.93 | Mlig455_056275 | Neo: - Age: - |
CHRNA7 | 0.95 | - | - | - | - | - | 0.950 | Mlig455_056275 {REF} {Length: 3506} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=176.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=131.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=255, Expect=4e-76]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=251, Expect=5e-75]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=250, Expect=2e-74]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=245, Expect=6e-73]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=237, Expect=7e-70]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=234, Expect=6e-69]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=271, Expect=1e-82]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=254, Expect=1e-76]} {Smed: dd_Smed_v6_18201_0_1, dd_Smed_v6_18201_0_1, [Score=471, Expect=8e-158]} {RNA1509_49660} {RNA1310_35095} {RNA815_30373} |